Refractory invasive pulmonary aspergillosis due to Aspergillus flavus detected with the combination of two in-house Aspergillus qPCR.


Journal

Journal de mycologie medicale
ISSN: 1773-0449
Titre abrégé: J Mycol Med
Pays: France
ID NLM: 9425651

Informations de publication

Date de publication:
Mar 2023
Historique:
received: 09 09 2022
revised: 31 10 2022
accepted: 07 11 2022
pubmed: 15 11 2022
medline: 22 3 2023
entrez: 14 11 2022
Statut: ppublish

Résumé

We present a case of probable invasive pulmonary aspergillosis due to Aspergillus flavus, in a female patient treated for an acute myeloid leukemia. Two weeks after an allogenic stem cell transplantation a probable invasive pulmonary aspergillosis was diagnosed based on thoracic imaging combined with positive galactomannan antigen and positive in-house mitochondrial Aspergillus qPCR in serum. Although an antifungal treatment was initiated, Aspergillus qPCR and galactomannan antigen remained positive in serum and worsening of the thoracic lesions was observed. The discordance between the negativity of the in-house ribosomal Aspergillus qPCR (specific to A. fumigatus) and the positivity of the in-house mitochondrial Aspergillus qPCR (targeting A. fumigatus and some other Aspergillus) allowed the suspicion of a thermophilic Aspergillus species that was not A. fumigatus. No strain was obtained in culture but the involvement of A. flavus was confirmed using a specific A. flavus qPCR. This case illustrated the usefulness of our original strategy combining two different in-house Aspergillus qPCRs, in addition to galactomannan assay, to diagnose invasive aspergillosis in hematology patients.

Identifiants

pubmed: 36375310
pii: S1156-5233(22)00107-X
doi: 10.1016/j.mycmed.2022.101350
pii:
doi:

Substances chimiques

Mannans 0
Galactose X2RN3Q8DNE

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

101350

Informations de copyright

Copyright © 2022 SFMM. Published by Elsevier Masson SAS. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare no conflict of interest.

Auteurs

Adrien Caillet (A)

Hematology Department, Besançon University Hospital, Besançon 25000, France.

Anne-Pauline Bellanger (AP)

Chrono-Environnement CNRS 6249 Research Team, Franche-Comté University, Besançon 25000, France; Parasitology-Mycology Department, Besançon University Hospital, Besançon 25000, France. Electronic address: apbellanger@chu-besancon.fr.

Jean Christophe Navellou (JC)

Medical Intensive Care Department, Besançon University Hospital, Besançon 25000, France.

Etienne Daguindau (E)

Hematology Department, Besançon University Hospital, Besançon 25000, France.

Steffi Rocchi (S)

Chrono-Environnement CNRS 6249 Research Team, Franche-Comté University, Besançon 25000, France; Parasitology-Mycology Department, Besançon University Hospital, Besançon 25000, France.

Emeline Scherer (E)

Chrono-Environnement CNRS 6249 Research Team, Franche-Comté University, Besançon 25000, France; Parasitology-Mycology Department, Besançon University Hospital, Besançon 25000, France.

Ana Berceanu (A)

Hematology Department, Besançon University Hospital, Besançon 25000, France.

Laurence Millon (L)

Chrono-Environnement CNRS 6249 Research Team, Franche-Comté University, Besançon 25000, France; Parasitology-Mycology Department, Besançon University Hospital, Besançon 25000, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH